Wilms Tumor Treatment Market

Wilms Tumor Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Wilms Tumor Treatment Market: Introduction

Wilms tumor is a rare type of kidney cancer which is usually found in children. Wilms tumor is called ‘Nephroblastoma’. Usually, it affects children between ages 3 to 4 and in some of the exceptional cases, it has been observed in children of age 5. This disease is uncommon after the age of 6. Roughly, 6% to 12% of children with Wilms tumor have more than one tumor in same kidney. This tumor mostly affects one kidney in children. In an exceptional case, it affects both the kidneys at the same time. Approximately 6% to 8% of children with Wilms tumor suffer from tumors in both kidneys. Some of the common symptoms seen in children suffering from this disease are fever, abdominal pain and swelling, and blood loss during urination.
In the last few years, the diagnosis and treatment of the Wilms tumor is vastly improved. It is also helping majorly in prognosis for children suffering from this disease. If appropriate treatment and care is provided, the prognosis of the tumor is very good. The survival rate for children’s disease has improved to 80%–90%.
In the U.S., the most of the children suffering from Wilms tumor are treated in clinical trials under Children’s Oncology group. One of the main goal of this group is to cure as many children as possible while limiting the side effects.
The incidence of Wilms tumor in children below 15 years is roughly 7.2 cases per one million children. Research findings also suggest that this tumor is slightly more amongst girls as compared to boys precisely in the U.S. and Africa.

Key Drivers of Global Wilms Tumor Treatment Market

Advancements in techniques due to rise in improved diagnostic products and treatment therapies and rise in births per year are some of the key elements which are expected to drive global Wilms tumor treatment market in the next few years
Additionally, macro-economic factors such as rise in expenditure on research & development to discover novel therapies and products for treatment of Wilms tumor are expected to drive the global Wilms tumor treatment market in the next few years. However, factors such as high cost of the treatment, lack of skilled professionals may hinder the global Wilms tumor treatment market.

North America to Hold Major Share of Global Wilms Tumor Treatment Market

As per current scenario, due to high incidence rate, North America dominates the Wilms tumor treatment market, followed by Africa and Europe. For example, according to the 2015s research findings by American Society of Cancer, every year, roughly 500 new cases of Wilms tumor are diagnosed in the U.S. Wilms tumor is comparatively more common in Africa region compared to East Asia.

Key Players Operating in Global Market

The global Wilms tumor treatment market is highly fragmented with major manufacturers adopting various strategies to gain maximum market share. Some companies have their presence in this market, while some of them have their drugs in the pipeline for clinical trials.

Some of the key players operating in the global Wilms tumor treatment market are: